Generali Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.14M Buy
255,024
+48,630
+24% +$1.27M 0.11% 171
2026
Q1
$5.8M Sell
206,394
-118,944
-37% -$3.17M 0.12% 168
2025
Q4
$8.1M Buy
325,338
+116,348
+56% +$2.93M 0.17% 121
2025
Q3
$5.33M Sell
208,990
-93,749
-31% -$2.31M 0.11% 170
2025
Q2
$7.34M Buy
302,739
+46,785
+18% +$1.09M 0.17% 128
2025
Q1
$6.49M Sell
255,954
-178,965
-41% -$4.68M 0.16% 137
2024
Q4
$11.5M Buy
+434,919
New +$11.8M 0.29% 70

Other funds holding PFE

Generali Asset Management's PFE Position: Q2 2026 in Review

Generali Asset Management increased its Pfizer (PFE) stake by 24% in Q2 2026, buying an estimated $1.27M and bringing the position to 255,024 shares worth $6.14M. The position accounts for 0.11% of the portfolio, ranked #171.

Generali Asset Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.5M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Generali Asset Management held 255,024 shares of Pfizer worth $6.14M as of Q2 2026.
  • Generali Asset Management bought 48,630 Pfizer shares in Q2 2026, an estimated $1.27M.
  • Pfizer made up 0.11% of Generali Asset Management's portfolio in Q2 2026, its #171 holding.
  • Generali Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Pfizer position peaked at $11.5M in Q4 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.